LifeMD Inc reports results for the quarter ended March 31 - Earnings Summary

LifeMD

07/05/2025 24:01

LifeMD Inc LFMD.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -19 cents.  The mean expectation of seven analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -11 cents tozero cents per share.

Revenue rose 48.8% to $65.70 million from a year ago; analysts expected $62.55 million.

LifeMD Inc's reported EPS for the quarter was 1 cent​.

The company reported quarterly net income of $608 thousand.

LifeMD Inc shares had risen by 38.6% this quarter and gained 52.3% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 11.9% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for LifeMD Inc is $12.00

This summary was machine generated from LSEG data May 6 at 11:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.05
0.01
Beat
Dec. 31 2024
-0.05
-0.02
Beat
Sep. 30 2024
-0.12
-0.14
Missed
Jun. 30 2024
-0.12
-0.19
Missed